Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Nutzen der kardialen CT zur Beurteilung verzögerter Kontrastverstärkung bei dilatativer Kardiomyopathie [Utility of cardiac CT for evaluating delayed contrast enhancement in dilated cardiomyopathy]

V. Cerny, P. Kuchynka, J. Marek, L. Lambert, M. Masek, T. Palecek, D. Ambroz, A. Linhart, J. Danes,

. 2017 ; 42 (8) : 776-780. [pub] 20161215

Jazyk angličtina Země Německo

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19013188
E-zdroje Online Plný text

NLK ProQuest Central od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2005-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-02-01 do Před 1 rokem

BACKGROUND: The presence of myocardial fibrosis is associated with adverse outcome in dilated cardiomyopathy (DCM). Delayed contrast-enhanced cardiac magnetic resonance (DE-CMR) currently represents the gold standard in noninvasive evaluation of myocardial scarring. However, a significant number of patients are unable to undergo DE-CMR study for various reasons. We sought to determine the diagnostic accuracy of cardiac CT (CCT) compared with CMR in the investigation of the presence of delayed contrast enhancement (DCE) in subjects with DCM. METHODS: We prospectively enrolled 17 consecutive patients with DCM, who were initially referred to our institution because of recently manifested heart failure due to unexplained left ventricular systolic dysfunction. In all subjects, CCT and DE-CMR were performed within 1 week. RESULTS: CCT and DE-CMR showed satisfactory agreement in detecting DCE (agreement in 82% cases, κ = 0.56) with 50% sensitivity, 100% specificity, and a positive predictive value of 100%. CONCLUSION: CCT may be a valuable method for detecting DCE in patients with DCM. CCT thus might be considered as an alternative method to DE-CMR in the assessment of the presence and extent of myocardial fibrosis in subjects who are not suitable for DE-CMR examination.

Utility of cardiac CT for evaluating delayed contrast enhancement in dilated cardiomyopathy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19013188
003      
CZ-PrNML
005      
20190409151256.0
007      
ta
008      
190405s2017 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00059-016-4515-4 $2 doi
035    __
$a (PubMed)27981361
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Cerny, V $u Department of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
245    10
$a Nutzen der kardialen CT zur Beurteilung verzögerter Kontrastverstärkung bei dilatativer Kardiomyopathie / $c V. Cerny, P. Kuchynka, J. Marek, L. Lambert, M. Masek, T. Palecek, D. Ambroz, A. Linhart, J. Danes,
246    31
$a Utility of cardiac CT for evaluating delayed contrast enhancement in dilated cardiomyopathy.
520    9_
$a BACKGROUND: The presence of myocardial fibrosis is associated with adverse outcome in dilated cardiomyopathy (DCM). Delayed contrast-enhanced cardiac magnetic resonance (DE-CMR) currently represents the gold standard in noninvasive evaluation of myocardial scarring. However, a significant number of patients are unable to undergo DE-CMR study for various reasons. We sought to determine the diagnostic accuracy of cardiac CT (CCT) compared with CMR in the investigation of the presence of delayed contrast enhancement (DCE) in subjects with DCM. METHODS: We prospectively enrolled 17 consecutive patients with DCM, who were initially referred to our institution because of recently manifested heart failure due to unexplained left ventricular systolic dysfunction. In all subjects, CCT and DE-CMR were performed within 1 week. RESULTS: CCT and DE-CMR showed satisfactory agreement in detecting DCE (agreement in 82% cases, κ = 0.56) with 50% sensitivity, 100% specificity, and a positive predictive value of 100%. CONCLUSION: CCT may be a valuable method for detecting DCE in patients with DCM. CCT thus might be considered as an alternative method to DE-CMR in the assessment of the presence and extent of myocardial fibrosis in subjects who are not suitable for DE-CMR examination.
650    _2
$a dospělí $7 D000328
650    _2
$a dilatační kardiomyopatie $x diagnostické zobrazování $7 D002311
650    _2
$a kohortové studie $7 D015331
650    _2
$a kontrastní látky $x farmakokinetika $7 D003287
650    _2
$a endomyokardiální fibróza $x diagnostické zobrazování $7 D004719
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a vylepšení obrazu $7 D007089
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a počítačová rentgenová tomografie $x metody $7 D014057
650    _2
$a dysfunkce levé srdeční komory $x diagnostické zobrazování $7 D018487
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kuchynka, P $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. kuchynkap@seznam.cz.
700    1_
$a Marek, J $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Lambert, L $u Department of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Masek, M $u Department of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Palecek, T $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Ambroz, D $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Linhart, A $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Danes, J $u Department of Radiology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
773    0_
$w MED00002031 $t Herz $x 1615-6692 $g Roč. 42, č. 8 (2017), s. 776-780
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27981361 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190409151311 $b ABA008
999    __
$a ok $b bmc $g 1392498 $s 1051493
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 42 $c 8 $d 776-780 $e 20161215 $i 1615-6692 $m Herz $n Herz $x MED00002031
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...